Market by Product and Service, Type, Application, Technology, Industry Verticals, and Geography | Forecast 2021-2028
Triton Market Research’s detailed analysis of the global multiplex assay depicts that, based on revenue, the market is estimated to grow at a CAGR of 8.67% during the forecasting years 2021-2028. In 2020, the market gained $3143.14 million and is likely to acquire $7933.87 million by 2028.
Report scope can be customized per your requirements. Request For Customization
The multiplex assays market is witnessing tremendous growth due to increased R&D activities in pharmaceuticals to treat several diseases. In addition, clinical trials use these assays as they decrease the cost of manual labor and research, enhancing the efficiency of therapies and experiments.
Identifying biomarkers for diseases such as cancer, neurological disorders, and cardiovascular disorders provides a deeper understanding of the disease mechanism. In addition, this helps understand the interaction of drugs and their effects on the metabolic pathway to help develop novel drugs. Thus, protein-based multiplex assays possess a high potential to identify new clinical biomarkers for early detection and diagnosis of diseases and discover new therapeutic targets from accessible bio-specimens, thereby augmenting the multiplex assay market’s growth.
Triton’s study aims to get an overview of the multiplex assay market in terms of various factors. Within this report, the key insight and the market summary regarding the market have been discussed. Also, the Impact of COVID-19 on the market, key buying outlook, Porter’s five forces model, market attractiveness matrix, and vendor scorecard have been studied in detail.
Market drivers like the adoption of personalized medicines and the high adoption of multiplex assays over traditional methods are driving the studied market’s growth. However, the industry faces market restraints like the dearth of skilled professionals possessing advanced laboratory expertise and legal trends related to environmental safety, obstructing the global market’s growth.
Key opportunities like funding for R&D activities by various government agencies and companies and emerging economies offering lucrative growth opportunities can be leveraged by the market to reach its projected growth.
Major geographies covered in the multiplex assay market are:
• North America: Canada and United States
• Asia-Pacific: New Zealand & Australia, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific
• Europe: Russia, Spain, The United Kingdom, Germany, France, Italy, and Rest of Europe
• Latin America: Mexico, Brazil, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa
The segmentation analysis of the multiplex assay market includes:
• Market by Product and Service:
o Reagents and Consumables
o Instruments and Accessories
o Software and Services
• Market by Type:
o Protein-Based Multiplex Assay
o Nucleic Acid-Based Multiplex Assay
o Other Multiplex Assay Types
• Market by Application:
o Research and Development
o Clinical Diagnostics
o Companion Diagnostics
• Market by Technology:
o Multiplex Protein Microarray
o Multiplex PCR
o Other Technologies
• Market by Industry Verticals:
o Pharmaceutical & Biotechnology Companies
o Research Institutes
o Clinical Laboratories
o Hospitals
The key players engaged in the multiplex assay market are Abcam, Becton Dickinson and Company, Siemens Healthineers AG, Merck Millipore, Bio Rad Laboratories Inc, Olink Proteomics AB, Bio Techne corporation, F Hoffmann La Roche, Illumina Inc, Seegene Inc, Agilent Technologies Inc, Luminex Corporation, Meso Scale Diagnostics LLC, Qiagen NV, Randox Laboratories Ltd, and Thermo Fisher Scientific Inc.
Market By Type, Application, E ..
VIEW REPORT
Market By Offerings, Technolog ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT1. GLOBAL
MULTIPLEX ASSAY MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON MULTIPLEX ASSAY MARKET
2.2. KEY
INSIGHTS
2.3. PORTER’S
FIVE FORCES MODEL
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. COMPETITIVE
RIVALRY
2.4. KEY
BUYING OUTLOOK
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
MARKET STRATEGIES
2.7.1. CONTRACTS
AND PARTNERSHIPS
2.7.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.7.3. ACQUISITIONS
& MERGERS
2.7.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.8. KEY
DRIVERS
2.8.1. ADOPTION
OF PERSONALIZED MEDICINES
2.8.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.9. KEY
RESTRAINTS
2.9.1. DEARTH
OF SKILLED PROFESSIONALS
2.9.2. LEGAL
TRENDS RELATED TO ENVIRONMENTAL SAFETY
2.10. KEY
OPPORTUNITIES
2.10.1. FUNDING
FOR R&D ACTIVITIES BY VARIOUS GOVERNMENT AGENCIES AND COMPANIES
2.10.2. EMERGING
ECONOMIES OFFERING LUCRATIVE GROWTH OPPORTUNITIES
3. GLOBAL
MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. GLOBAL
MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. GLOBAL
MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. GLOBAL
MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. GLOBAL
MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICALS
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. GLOBAL
MULTIPLEX ASSAY MARKET – REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY PRODUCT AND SERVICE
8.1.2. MARKET
BY TYPE
8.1.3. MARKET
BY APPLICATION
8.1.4. MARKET
BY TECHNOLOGY
8.1.5. MARKET
BY INDUSTRY VERTICALS
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.2. CANADA
8.2. EUROPE
8.2.1. MARKET
BY PRODUCT AND SERVICE
8.2.2. MARKET
BY TYPE
8.2.3. MARKET
BY APPLICATION
8.2.4. MARKET
BY TECHNOLOGY
8.2.5. MARKET
BY INDUSTRY VERTICALS
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. GERMANY
8.2.6.2. FRANCE
8.2.6.3. UNITED
KINGDOM
8.2.6.4. ITALY
8.2.6.5. RUSSIA
8.2.6.6. SPAIN
8.2.6.7. REST
OF EUROPE
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY PRODUCT AND SERVICE
8.3.2. MARKET
BY TYPE
8.3.3. MARKET
BY APPLICATION
8.3.4. MARKET
BY TECHNOLOGY
8.3.5. MARKET
BY INDUSTRY VERTICALS
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.2. JAPAN
8.3.6.3. INDIA
8.3.6.4. AUSTRALIA
& NEW ZEALAND
8.3.6.5. SOUTH
KOREA
8.3.6.6. ASEAN
COUNTRIES
8.3.6.7. REST
OF ASIA-PACIFIC
8.4. LATIN
AMERICA
8.4.1. MARKET
BY PRODUCT AND SERVICE
8.4.2. MARKET
BY TYPE
8.4.3. MARKET
BY APPLICATION
8.4.4. MARKET
BY TECHNOLOGY
8.4.5. MARKET
BY INDUSTRY VERTICALS
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. BRAZIL
8.4.6.2. MEXICO
8.4.6.3. REST
OF LATIN AMERICA
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY PRODUCT AND SERVICE
8.5.2. MARKET
BY TYPE
8.5.3. MARKET
BY APPLICATION
8.5.4. MARKET
BY TECHNOLOGY
8.5.5. MARKET
BY INDUSTRY VERTICALS
8.5.6. COUNTRY
ANALYSIS
8.5.6.1. SAUDI
ARABIA
8.5.6.2. UNITED
ARAB EMIRATES
8.5.6.3. TURKEY
8.5.6.4. SOUTH
AFRICA
8.5.6.5. REST
OF MIDDLE EAST & AFRICA
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
9.2. AGILENT
TECHNOLOGIES INC
9.3. BECTON
DICKINSON AND COMPANY
9.4. BIO
RAD LABORATORIES INC
9.5. BIO
TECHNE CORPORATION
9.6. F
HOFFMANN LA ROCHE
9.7. ILLUMINA
INC
9.8. LUMINEX
CORPORATION
9.9. MERCK
MILLIPORE
9.10. MESO
SCALE DIAGNOSTICS LLC
9.11. OLINK
PROTEOMICS AB
9.12. QIAGEN
NV
9.13. RANDOX
LABORATORIES LTD
9.14. SEEGENE
INC
9.15. SIEMENS
HEALTHINEERS AG
9.16. THERMO
FISHER SCIENTIFIC INC
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.1.1. OBJECTIVES
OF STUDY
10.1.2. SCOPE
OF STUDY
10.2. SOURCES
OF DATA
10.2.1. PRIMARY
DATA SOURCES
10.2.2. SECONDARY
DATA SOURCES
10.3. RESEARCH
METHODOLOGY
10.3.1. EVALUATION
OF PROPOSED MARKET
10.3.2. IDENTIFICATION
OF DATA SOURCES
10.3.3. ASSESSMENT
OF MARKET DETERMINANTS
10.3.4. DATA
COLLECTION
10.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: GLOBAL MULTIPLEX
ASSAY MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: LIST OF BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: LIST OF NEW PRODUCT
LAUNCHES & DEVELOPMENTS
TABLE 7: GLOBAL MULTIPLEX
ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 8: GLOBAL MULTIPLEX
ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: GLOBAL MULTIPLEX
ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 10: GLOBAL MULTIPLEX ASSAY
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 11: GLOBAL MULTIPLEX ASSAY
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 12: GLOBAL MULTIPLEX ASSAY
MARKET, REGIONAL OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA
MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA
MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA
MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA
MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 17: NORTH AMERICA MULTIPLEX
ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA
MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 19: EUROPE MULTIPLEX
ASSAY, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 20: EUROPE MULTIPLEX ASSAY
MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 21: EUROPE MULTIPLEX ASSAY
MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 22: EUROPE MULTIPLEX ASSAY
MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 23: EUROPE MULTIPLEX ASSAY
MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 24: EUROPE MULTIPLEX ASSAY
MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC MULTIPLEX
ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 31: LATIN AMERICA
MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 32: LATIN AMERICA
MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 33: LATIN AMERICA
MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 34: LATIN AMERICA
MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 35: LATIN AMERICA
MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 36: LATIN AMERICA
MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2021-2028 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 40: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 41: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND AFRICA
MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 1: GLOBAL MULTIPLEX ASSAY MARKET, REGIONAL
OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT
AND SERVICE, 2020 & 2028 (IN %)
FIGURE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS
AND CONSUMABLES, 2021-2028 (IN $ MILLION)
FIGURE 4: GLOBAL MULTIPLEX ASSAY MARKET, BY
INSTRUMENTS AND ACCESSORIES, 2021-2028 (IN $ MILLION)
FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE
AND SERVICES, 2021-2028 (IN $ MILLION)
FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE,
2020 & 2028 (IN %)
FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY
PROTEIN-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC
ACID-BASED MULTIPLEX ASSAY, 2021-2028 (IN $ MILLION)
FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER
MULTIPLEX ASSAYS, 2021-2028 (IN $ MILLION)
FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION,
2020 & 2028 (IN %)
FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND
DEVELOPMENT, 2021-2028 (IN $ MILLION)
FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 13: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION
DIAGNOSTICS, 2021-2028 (IN $ MILLION)
FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY,
2020 & 2028 (IN %)
FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX
PROTEIN MICROARRAY, 2021-2028 (IN $ MILLION)
FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX
PCR, 2021-2028 (IN $ MILLION)
FIGURE 17: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER
TECHNOLOGIES, 2021-2028 (IN $ MILLION)
FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY
VERTICALS, 2020 & 2028 (IN %)
FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH
INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL
LABORATORIES, 2021-2028 (IN $ MILLION)
FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS,
2021-2028 (IN $ MILLION)
FIGURE 24: UNITED STATES MULTIPLEX ASSAY MARKET 2021-2028
(IN $ MILLION)
FIGURE 25: CANADA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 26: GERMANY MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 27: FRANCE MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 28: UNITED KINGDOM MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 29: ITALY MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 30: RUSSIA MULTIPLEX ASSAY MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: SPAIN MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 32: REST OF EUROPE MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 33: CHINA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 34: JAPAN MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 35: INDIA MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 36: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY
MARKET 2021-2028 (IN $ MILLION)
FIGURE 37: SOUTH KOREA MULTIPLEX ASSAY MARKET 2021-2028
(IN $ MILLION)
FIGURE 38: ASEAN COUNTRIES MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 39: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 40: BRAZIL MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 41: MEXICO MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 42: REST OF LATIN AMERICA MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 43: SAUDI ARABIA MULTIPLEX ASSAY MARKET 2021-2028
(IN $ MILLION)
FIGURE 44: UNITED ARAB EMIRATES MULTIPLEX ASSAY MARKET
2021-2028 (IN $ MILLION)
FIGURE 45: TURKEY MULTIPLEX ASSAY MARKET 2021-2028 (IN $
MILLION)
FIGURE 46: SOUTH AFRICA MULTIPLEX ASSAY MARKET 2021-2028
(IN $ MILLION)
FIGURE 47: REST OF MIDDLE EAST & AFRICA MULTIPLEX
ASSAY MARKET 2021-2028 (IN $ MILLION)